IMNM Immunome, Inc.
Healthcare$21.94+0.00%OpenMarket Cap: $2.10B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$36.20
Target (Median)
$36.00
Target Range
$32.00 - $40.00
Upside from current price: 65.0%
Rating Distribution
2 Strong Buy12 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | Leerink Partners | maintain | Outperform | Outperform |
| 2026-05-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-04 | Stephens & Co. | maintain | Overweight | Overweight |
| 2026-03-04 | Craig-Hallum | maintain | Buy | Buy |
| 2026-01-15 | Wedbush | maintain | Outperform | Outperform |
| 2025-12-16 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2025-12-16 | Guggenheim | maintain | Buy | Buy |
| 2025-12-16 | Lake Street | maintain | Buy | Buy |
| 2025-11-17 | Stephens & Co. | maintain | Overweight | Overweight |
| 2025-08-25 | Guggenheim | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.08 | $74.0M | 10 |
| Sun Dec 31 | $-1.06 | $239.9M | 9 |
| Mon Dec 31 | $-0.03 | $400.7M | 3 |
| Tue Dec 31 | $1.35 | $619.7M | 3 |